Evidence for the integration of total and free testosterone levels in the management of prostate cancer.

Linda My Huynh Erica HuangMaxwell ToweKarren LiangFarouk M El KhatibFaysal A YafiThomas E Ahlering

Published in: BJU international (2021)

In contrast to popular belief, testosterone remained stable in men aged 40-80 years, whereas free testosterone decreased by 2-3%/year. Low cFT was an independent predictor of very-high-risk PCa and BCR.

Keyphrases

replacement therapy
prostate cancer
acute lymphoblastic leukemia
radical prostatectomy
magnetic resonance
tyrosine kinase
smoking cessation
magnetic resonance imaging
middle aged
computed tomography